TNFRSF18 and Miyoshi myopathy: We observed significant reduction of growth of MM cells in mice that received GITR-overexpressing cells, compared to control groups, suggesting that GITR is a critical regulator of tumor growth in MM cells both in vitro and in vivo (Figure 3d-3e).